BAY79-4980

· Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY79-4980, covering 2011-08-17 to 2011-08-17. Get the full timeline:

Most recent: Clinical Trial Update: BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A [Phase 2]